Active surveillance is the preferred approach to clinical stage i testicular cancer

Craig R. Nichols, Bruce Roth, Peter Albers, Lawrence H. Einhorn, Richard Foster, Siamak Daneshmand, Michael Jewett, Padraig Warde, Christopher J. Sweeney, Clair Beard, Tom Powles, Scott Tyldesley, Alan So, Christopher Porter, Semra Olgac, Karim Fizazi, Brandon Hayes-Lattin, Peter Grimison, Guy Toner, Richard CathomasCarsten Bokemeyer, Christian Kollmannsberger

Research output: Contribution to journalComment/debate

104 Scopus citations
Original languageEnglish (US)
Pages (from-to)3490-3493
Number of pages4
JournalJournal of Clinical Oncology
Volume31
Issue number28
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nichols, C. R., Roth, B., Albers, P., Einhorn, L. H., Foster, R., Daneshmand, S., Jewett, M., Warde, P., Sweeney, C. J., Beard, C., Powles, T., Tyldesley, S., So, A., Porter, C., Olgac, S., Fizazi, K., Hayes-Lattin, B., Grimison, P., Toner, G., ... Kollmannsberger, C. (2013). Active surveillance is the preferred approach to clinical stage i testicular cancer. Journal of Clinical Oncology, 31(28), 3490-3493. https://doi.org/10.1200/JCO.2012.47.6010